Axsome Therapeutics Inc (AXSM)
NASDAQ:AXSM

Axsome Therapeutics (AXSM) Stock Price & Analysis

1,458 Followers

AXSM Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$20.63 - $82.85
Previous Close$69.8
Volume812.04K
Average Volume (3M)831.83K
Market Cap
$3.04B
Enterprise Value$2.94B
Total Cash (Recent Filing)$246.51M
Total Debt (Recent Filing)$147.72M
Price to Earnings (P/E)-18.4
Beta0.22
Aug 09, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.80
Shares Outstanding43,573,213
10 Day Avg. Volume620,987
30 Day Avg. Volume831,831
Standard Deviation0.41
R-Squared0.06
Alpha0.09
Financial Highlights & Ratios
Price to Book (P/B)105.78
Price to Sales (P/S)31.37
Price to Cash Flow (P/CF)-28.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue20.35
Enterprise Value/Gross Profit62.96
Enterprise Value/Ebitda-21.59
Forecast
Price Target Upside50.62% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering8


Financials

Annual

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.

---

AXSM FAQ

What was Axsome Therapeutics Inc’s price range in the past 12 months?
Axsome Therapeutics Inc lowest stock price was $20.63 and its highest was $82.85 in the past 12 months.
    What is Axsome Therapeutics Inc’s market cap?
    Currently, no data Available
    When is Axsome Therapeutics Inc’s upcoming earnings report date?
    Axsome Therapeutics Inc’s upcoming earnings report date is Aug 09, 2023 which is in 74 days.
      How were Axsome Therapeutics Inc’s earnings last quarter?
      Axsome Therapeutics Inc released its earnings results on May 08, 2023. The company reported -$0.26 earnings per share for the quarter, beating the consensus estimate of -$1.304 by $1.044.
        Is Axsome Therapeutics Inc overvalued?
        According to Wall Street analysts Axsome Therapeutics Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Axsome Therapeutics Inc pay dividends?
          Axsome Therapeutics Inc does not currently pay dividends.
          What is Axsome Therapeutics Inc’s EPS estimate?
          Axsome Therapeutics Inc’s EPS estimate is -$1.27.
            How many shares outstanding does Axsome Therapeutics Inc have?
            Axsome Therapeutics Inc has 43,573,210 shares outstanding.
              What happened to Axsome Therapeutics Inc’s price movement after its last earnings report?
              Axsome Therapeutics Inc reported an EPS of -$0.26 in its last earnings report, beating expectations of -$1.304. Following the earnings report the stock price went up 5.411%.
                Which hedge fund is a major shareholder of Axsome Therapeutics Inc?
                Among the largest hedge funds holding Axsome Therapeutics Inc’s share is Fairmount Funds Management Llc. It holds Axsome Therapeutics Inc’s shares valued at 124M.

                  ---

                  Axsome Therapeutics Stock Smart Score

                  The Axsome Therapeutics stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Axsome Therapeutics Inc

                  Axsome Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel therapies for the management of central nervous system disorders. Its product candidates include AXS-02 and AXS-06 which are developing for multiple indications. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

                  ---

                  Top 5 ETFs holding AXSM

                  Name
                  Market Value
                  Smart Score
                  Vanguard Health Care ETF
                  $8.14M
                  8
                  iShares NASDAQ US Biotechnology UCITS ETF
                  $1.58M
                  8
                  Schwab U.S. Broad Market ETF
                  $1.37M
                  8
                  Fidelity MSCI Health Care Index ETF
                  $1.29M
                  8
                  Fidelity Nasdaq Composite Index ETF
                  $770.69K
                  8
                  Up to five ETFs with an Outperform Smart Score that hold AXSM. The ETFs are listed according to market value of AXSM within the ETF

                  ---

                  Forecast EPS vs Actual EPS


                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Elanco Animal Health
                  Intra-Cellular Therapies
                  Harmony Biosciences Holdings
                  Prestige Consumer Healthcare

                  Popular Stocks

                  ---
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis